PeptidePedia The community reference

User talk:BiliaryBea

Editor talk page·2 messages

This is the talk page for the editor BiliaryBea. Messages left here are public and are signed. Please add new messages at the bottom, and sign with four tildes.

I think we disagree about AmbioPharm

We have now reverted each other twice on AmbioPharm, which is a sign that the disagreement is substantive rather than accidental. My reading is that the source supports the weaker of the two claims. Rather than continue in edit summaries, shall we put it on the article talk page and let someone else weigh in? — RetinopathyRex (talk) 15:35, 28 August 2025 (UTC)

Thank you for the note. I have proposed a wording that states the weaker claim and attributes the stronger one, which may satisfy both. — BiliaryBea (talk) 21:08, 29 August 2025 (UTC)

Denominator in Adverse effects of GLP-1 receptor agonists

Several incidences in Adverse effects of GLP-1 receptor agonists appear without their denominator, and one is given per patient-year while its neighbour is given per patient. As a table they cannot be read against each other. Do you have the source to hand to standardise them? — EndotoxinEd (talk) 12:13, 6 March 2026 (UTC)

Standardised — all of them are now per patient, with the exposure stated separately. — BiliaryBea (talk) 14:50, 7 March 2026 (UTC)